PET Imaging

Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.

The Centers for Medicare and Medicaid Services (CMS) recently released its final National Coverage Determination Reconsideration for Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease
News | PET Imaging
CMS Responds to Public Comments Received on Beta Amyloid PET Scan Proposed Coverage

October 24, 2023 — The Centers for Medicare and Medicaid Services (CMS) recently released its final National Coverage ...

Time October 24, 2023
arrow
Meilleur Technologies, Inc. announced a research collaboration agreement with the Alzheimer’s Disease Neuroimaging Initiative 4, ADNI4
News | Radiopharmaceuticals and Tracers
Meilleur Technologies Inc. Announces Use of the Next-Generation Amyloid PET Imaging Biomarker, NAV-4694, in the Alzheimer’s Disease Neuroimaging Initiative 4 (ADNI4)

October 20, 2023 — Meilleur Technologies, Inc. announced a research collaboration agreement with the Alzheimer’s Disease ...

Time October 20, 2023
arrow
Medicare leaves coverage determination for amyloid PET in dementia care to MACs
News | PET Imaging
CMS Expands Access to Beta Amyloid PET for Medicare Beneficiaries

October 18, 2023 — The Centers for Medicare and Medicaid Services (CMS) announced it will no longer require coverage ...

Time October 18, 2023
arrow
A global licensing agreement has been signed for the development and commercialization of SOFIE’s two investigational Gallium-68 and Fluorine-18 Fibroblast Activation Protein Inhibitors (FAPI) radiopharmaceutical diagnostics - [68Ga]FAPI-46 and outside-U.S. rights for [18F]FAPI-74
News | Radiopharmaceuticals and Tracers
SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE) ...

Time October 11, 2023
arrow
68Ga-ABY-025 PET/CT and 18F-FDG PET/CT images at baseline with 18F-FDG PET/CT follow-up after 2 cycles of treatment in biopsy-confirmed HER2-positive disease
News | Breast Imaging
Whole-body PET/CT Predicts Response to HER2-targeted Therapy in Metastatic Breast Cancer Patients

October 11, 2023 — A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth ...

Time October 11, 2023
arrow
POSLUMA (flotufolastat F 18) PET/CT image showing uptake in the prostate gland, consistent with primary prostate cancer.
News | Radiopharmaceuticals and Tracers
Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO

October 5, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 05, 2023
arrow
RefleXion Showcases Breakthrough SCINTIX Biology-Guided Radiotherapy
News | Radiation Therapy
RefleXion Showcases Breakthrough SCINTIX Biology-Guided Radiotherapy and Highlights New Research at ASTRO 2023 Meeting

September 28, 2023 — RefleXion Medical, a therapeutic oncology company, announced the company will showcase the ...

Time September 28, 2023
arrow
A modern collection of imaging innovations offers a new path to healthcare and medical research, framing a new era of medical diagnostic solutions
Feature | Magnetic Resonance Imaging (MRI) | By Robert L. Bard, MD, and Lennard M. Gettz, EdD
The Full Body Imaging Movement: A Strategic Upgrade of the MRI

Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...

Time September 25, 2023
arrow
Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT mаchines, using the perovskite-based photoconverters
News | X-Ray
Moscow Scientists Initiate Groundbreaking Testing of X-ray Machine Detectors

September 21, 2023 — Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT ...

Time September 21, 2023
arrow
The clinical study of Positron’s Affinity PET-CT is designed to provide key information that evaluate the new system and its full capabilities with multiple radiopharmaceuticals and new coronary flow software applications that will enhance physician’s diagnostic analysis
News | PET-CT
Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device

September 8, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce ...

Time September 08, 2023
arrow
The AURA 10 is now poised to help enhance surgical outcomes in the United States
News | PET-CT
XEOS Receives Approval by US FDA for the AURA 10 PET-CT Specimen Imager for the Operating Room

September 7, 2023 — The groundbreaking AURA 10 specimen imager by Belgian MedTech pioneer XEOS has been cleared by the ...

Time September 07, 2023
arrow
The iba Cyclone IKON
Feature | PET Imaging
PET Radiotracer Market anticipated to reach $3.2 Billion in Revenues by 2031

According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...

Time September 05, 2023
arrow
In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without the need for a biopsy
News | Prostate Cancer
PSMA PET/CT Waives the Need for Pre-imaging Biopsy in Elderly Patients

August 15, 2023 — In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid ...

Time August 15, 2023
arrow
Now radiology departments, imaging technologists and medical experts have a solution they can use to help tackle these challenges.
Sponsored Content | Case Study | Enterprise Imaging
Redefining Radiology

The healthcare industry faces many different types of obstacles in today’s challenging marketplace. Staff shortages ...

Time August 01, 2023
arrow
FDA-approved in May 2023, POSLUMA is commercially available through 36 radiopharmacies across the United States
News | Prostate Cancer
Blue Earth Diagnostics Announces Addition of POSLUMA (Flotufolastat F 18) Injection to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer

July 28, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 28, 2023
arrow
Scientists have found a new use for copper in magnetic resonance imaging (MRI) contrast agent design, that could help to create better images which help doctors diagnose patients’ conditions more easily and safely.
News | Magnetic Resonance Imaging (MRI)
Copper Could Help Create Clearer MRI Images and Improved Diagnosis

July 27, 2023 — Scientists have found a new use for copper in magnetic resonance imaging (MRI) contrast agent design ...

Time July 27, 2023
arrow
Researchers at Monash University have designed a new co-training AI algorithm for medical imaging that can effectively mimic the process of seeking a second opinion.
News | PET Imaging
PSMA PET Imaging Improves Accuracy of Predicting Prostate Cancer Recurrence

July 26, 2023 — A molecular imaging tool developed by researchers at the University of California’s two nationally ...

Time July 26, 2023
arrow
A collaboration to advance development of a fibroblast activation protein (FAP)-targeted PET diagnostic compound for a broad array of epithelial-derived cancers. 
News | Radiopharmaceuticals and Tracers
Ratio Therapeutics, In Collaboration with Lantheus and PharmaLogic, Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

July 25, 2023 — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative ...

Time July 25, 2023
arrow
Positron Corporation has entered an Novation Agreement with Shenyang Intelligent Neuclear Medical Technology Co, LTD (Intelligent Neuclear Medical), a wholly owned subsidiary of Neusoft Medical Systems (Neusoft.
News | PET-CT
Positron Corporation Enters New Manufacturing & Components Supplier Cooperative with Neusoft Medical Systems Subsidiary for New PET-CT Device

July 25, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce that ...

Time July 25, 2023
arrow
With uMI Panorama, United Imaging Continues to Push the Envelope on Whole-Body System Performance
News | PET-CT
United Imaging Introduces Next-Generation PET/CT Systems and Integrated Molecular Technology Platform at SNMMI

July 12, 2023 — United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment and ...

Time July 12, 2023
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now